Center-Authored Papers

Filters: Author is True, Lawrence D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Xenograft Model Antitumor Assays
Vaccine and Infectious Disease Institute
Urokinase-Type Plasminogen Activator
Tumor Markers, Biological
Treatment Outcome
Trans-Activators Human Biology Division
Trans-Activators
Klezovitch O, Risk M, Coleman I, Lucas JM, Null M, True LD, Nelson PS, Vasioukhin VI.  2008.  A causal role for ERG in neoplastic transformation of prostate epithelium.. Proceedings of the National Academy of Sciences of the United States of America. 105(6):2105-10. Abstract
Tissue Array Analysis
Time Factors
Tibia
Survival Rate
Stromal Cells
static Neoplasms
Specimen Processing Core Facility
Soft Tissue Neoplasms
Signal Transduction
Shared Resources
Qian DZ, Huang C-Y, O'Brien CA, Coleman IM, Garzotto M, True LD, Higano CS, Vessella R, Lange PH, Nelson PS et al..  2009.  Prostate cancer-associated gene expression alterations determined from needle biopsies.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(9):3135-42. Abstract
True LD, Zhang H, Ye M, Huang C-Y, Nelson PS, von Haller PD, Tjoelker LW, Kim J-S, Qian W-J, Smith RD et al..  2010.  CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 23(10):1346-56. Abstract